WIBC 93.1 FM

Sleep Duration Directly Impacts Atrial Fibrillation Risk, Study Finds

Atrial fibrillation is the most common form of heart rhythm disorder and is linked to serious complications, including stroke ...

CereVasc, Inc. Announces Publication of A Multi-Center Study Evaluating the eShunt® System in the Treatment of Patients with NPH

CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, today ...
ascopubs.org

ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine ...

Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation Eligible patients ...

Study identifies long-term health risks in testicular cancer survivors treated with contemporary chemotherapy

A large, multi-center study published online in the Journal of the National Comprehensive Cancer Network (JNCCN) provides new insight into the long-term health effects of contemporary chemotherapy ...
ascopubs.org

Prospective Multicenter Study Evaluating a Combined Circulating Tumor DNA and Circulating Tumor RNA Liquid Biopsy in Metastatic Non–Small Cell Lung Cancer (LIQUIK)

This multicenter, prospective study (ClinicalTrials.gov identifier: NCT04703153) enrolled patients across the United States and Singapore. Patients were tested with tissue NGS, LHM, and G360 ctDNA.

Prospective Multicenter Registry Study Reports High Local Tumor Control Following Resection with GammaTile® in Newly Diagnosed Brain Metastases

GT Medical Technologies, Inc., a company focused on improving the lives of patients with brain tumors, today announced a publication of prospective, multicenter Phase IV data from the ongoing ...
Medical Dialogues

Multi-Modal AI Cuts Mammography Workload by 43.8% While Preserving 100% Sensitivity: Study Finds

Effective Patient Triaging: Prospective clinical data demonstrated a significant reduction in recall rates for low-risk cases, decreasing from 7.6% to 5.7%, which minimizes nonessential follow-up ...

Adagio Medical (ADGM) announces successful results from US cardiac ablation feasibility study

Adagio Medical Holdings Inc. (NASDAQ:ADGM) is one of the best up and coming penny stocks to buy. On February 4, Adagio Medical Holdings announced the publication of results from its US Early ...